Microsampling for Omics Studies

Proteins in omics studies are measured using blood sample preparation workflows combined with proteomics approaches using mass spectrometry to measure hundreds of potential biomarkers simultaneously. This can be done with high specificity by using just a few microliters of blood or serum with microsampling devices.
Mitra® devices are intended as a specimen collector and for the storage and transport of blood. They are CE-IVD in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada and Ukraine. In the USA, Mitra devices are supplied as a Research-Use Only (RUO) product to assist in method development, other research-related and non-diagnostic activities. Mitra has not been validated for use with any diagnostic testing. The hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD. Outside of these territories, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use.